ClinicalTrials.gg
Not yet recruitingNCT07943884Updated Nov 17, 2026

Evaluation of Chronic and Acute Beetroot Juice Supplementation on Submaximal VO2 in High-Level Athletes

An interventional study of Acute beetroot concentrates and Subacute beetroot concentrates in No Condition. Healthy Subjects, sponsored by Université de Sherbrooke. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Other

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The goal of this randomized crossover clinical trial is to determine whether acute or subacute nitrate supplementation with concentrated beetroot juice improves submaximal exercise performance in elite athletes. The optimal nitrate supplementation regimen using concentrated beetroot juice has not yet been clearly established. The main questions it aims to answer are:

  • Does subacute nitrate supplementation, consisting of seven days of twice-daily Beet It Sport consumption followed by an additional dose on the morning of testing, improve submaximal exercise performance compared with acute nitrate supplementation alone?
  • Does subacute nitrate supplementation result in greater improvements in submaximal oxygen consumption (VO₂), time to exhaustion, and physiological responses during exercise than acute nitrate supplementation?

Researchers will compare the two nitrate supplementation regimens in the same athletes to determine which approach provides the greatest improvement in submaximal exercise performance. Participants will be randomly assigned to one of two groups, each completing both supplementation regimens in a different order, with a 2-4-week washout period between interventions to minimize potential carryover effects.

Participants will:

  • Complete the recruitment and informed consent process.
  • Attend three study visits, including an initial VO₂ max assessment and subsequent exercise testing visits.
  • Complete both supplementation regimens in a randomized crossover design:
  • Subacute nitrate supplementation: Consume 70 mL of Beet It Sport twice daily for seven days before the exercise test, followed by 140 mL on the morning of the test.
  • Acute nitrate supplementation: Consume 70 mL of placebo twice daily for seven days before the exercise test, followed by 140 mL of Beet It Sport on the morning of the test.
  • Undergo exercise testing, including submaximal VO₂ assessment and a time-to-exhaustion test, as well as measurements of vital signs and capillary blood lactate levels.
  • Complete a questionnaire assessing adherence to the assigned supplementation regimen.

No additional follow-up will be required after the study visits. The findings may help establish the most effective nitrate supplementation regimen using concentrated beetroot juice to optimize submaximal exercise performance in elite athletes.

02

Conditions studied

  • No Condition. Healthy Subjects
03

In context

Lead sponsor

Université de Sherbrooke is the lead sponsor of 297 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult male or female aged 30 years or younger
  • Active member of the University of Sherbrooke Vert \& Or cross-country or athletics team, or the Sherbrooke Athletics Club

Exclusion criteria

Exclusion Criteria:

  • Daily beetroot juice consumption
  • Injury limiting participation in competitions or training
  • Beetroot or lemon allergy
  • Known cardiac, pulmonary, or metabolic disease except treated asthma
  • Use of medications other than or asthma inhalers
  • Smoking or vaping
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
18 participants (estimated)

Study arms

  • Other
    Acute Administration First

    Acute first

    Dietary Supplement: Acute beetroot concentrates

  • Other
    Subacute First

    Subacute first

    Dietary Supplement: Subacute beetroot concentrates

Interventions

  • Dietary supplementAcute beetroot concentrates

    Complete both supplementation regimens in a crossover design: * Acute nitrate supplementation: Consume 70 mL of placebo twice daily for seven days before the exercise test, followed by 140 mL of Beet It Sport on the morning of the test. * Subacute nitrate supplementation: Consume 70 mL of Beet It Sport twice daily for seven days before the exercise test, followed by 140 mL on the morning of the test.

  • Dietary supplementSubacute beetroot concentrates

    Complete both supplementation regimens in a randomized crossover design: * Subacute nitrate supplementation: Consume 70 mL of Beet It Sport twice daily for seven days before the exercise test, followed by 140 mL on the morning of the test. * Acute nitrate supplementation: Consume 70 mL of placebo twice daily for seven days before the exercise test, followed by 140 mL of Beet It Sport on the morning of the test.

06

What researchers measure

Primary outcomes

  1. Submaximal exercise test

    V02 max

    Time frame: 1 hours

Secondary outcomes

  1. Time to exhaustion test

    Time in secondes

    Time frame: 1 hour

  2. Capillary blood lactate concentrations during exercise testing

    (mmol/L)

    Time frame: 1 hour

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for Dec 2027, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 17, 2026
StartEst.
Jan 2027
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943884
Responsible party
Paul Farand (Chair of Medicine, Université de Sherbrooke) — Principal investigator
First posted
Nov 17, 2026
Start date
Jan 2027 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 17, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion